Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approach

BACKGROUND: Glioblastoma multiforme (GBM) is a brain tumour with a very high patient mortality rate, with a median survival of 47 weeks. This might be improved by the identification of novel diagnostic, prognostic and predictive therapy-response biomarkers, preferentially through the monitoring of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zupancic, Klemen, Blejec, Andrej, Herman, Ana, Veber, Matija, Verbovsek, Urska, Korsic, Marjan, Knezevic, Miomir, Rozman, Primoz, Turnsek, Tamara Lah, Gruden, Kristina, Motaln, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita, Warsaw 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110082/
https://www.ncbi.nlm.nih.gov/pubmed/25177240
http://dx.doi.org/10.2478/raon-2014-0014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110082/
https://www.ncbi.nlm.nih.gov/pubmed/25177240
http://dx.doi.org/10.2478/raon-2014-0014

Ejemplares similares